fda cleared immunoassay semaglutide detection clears first blood-based diagnostic test for Alzheimer's disease Semaglutide TFA | GLP-1R Agonist

You cannot supplement your way around a fundamental caloric and nutritional deficit

Cardiovascular outcome trials have demonstrated significant reductions in major adverse cardiovascular events with certain agents in this class (liraglutide, injectable semaglutide, and dulaglutide), leading to expanded indications for cardiovascular risk reduction

Recognizing obesity as a chronic disease shifts the focus from stigma and blame to effective treatment strategies that support overall health

This creates a dangerous bottleneck where highly toxic Phase I intermediates accumulate in the liver, leading to systemic toxicity, severe hepatic inflammation, and a cascading failure of the body's natural waste-removal systems